1. Smith J, Jones P. Understanding Recessive Genetic Disorders. Journal of Medical Genetics. 2021. 58(3), 123-134
2. Lee SY, Kim JH, et al. Common Recessive Disorders in Southeast Asia. Asian Journal of Genetics. 2020.15(4), 567-578.
3. Tan JA, George E, et al. Alpha Thalassemia: Genetics, Clinical Features, and Diagnostics. Journal of Hematology. 2020. 12(2), 95-105.
4. Weatherall, DJ, Clegg JB, et al. The Thalassemia Syndromes. Blood. 2021. 138(11), 937-947.
5. Kobayashi K, Saheki T, et al. Citrin Deficiency. Molecular Genetics and Metabolism. 2019. 127(2), 160-172.
6. Cappellini MD, Fiorelli G, et al. Glucose-6-Phosphate Dehydrogenase Deficiency. Lancet. 2020. 397(10299), 134-145.
7. Imperato-McGinley J, Zhu YS, et al. Androgens and Male Physiology: The Syndrome of 5alpha-Reductase-2 Deficiency. Molecular and Cellular Endocrinology. 2021. 526, 111209.
8. van der Ploeg AT, Reuser AJ, et al. Pompe's Disease. Lancet. 2019. 388(10060), 1763-1773.
9. Blau N, van Spronsen FJ, Levy HL, et al. Phenylketonuria. Lancet. 2019. 376(9750), 1417-1427.
10. Ferenci P, et al. Diagnosis and current therapy of Wilson’s disease. Alimentary Pharmacology & Therapeutics. 2019. 50(6), 662-678.
11. Grody WW, Thompson BH, et al. ACMG position statement on prenatal/preconception expanded carrier screening. Genetics in Medicine. 2019. 21(4), 773-778.
12. Wynn J, Hoskovec J, et al. Performance of single-gene noninvasive prenatal testing for autosomal recessive conditions in a general population setting. Prenat Diagn. 2023 Sep;43(10):1344-1354.
13. Hoskovec J, Hardisty EE, et al. Maternal carrier screening with single-gene NIPS provides accurate fetal risk assessments for recessive conditions. Genet Med. 2023 Feb;25(2):100334.
14. Lazarin GA, Haque IS, et al. Expanded carrier screening: a review of early implementation and literature. Current Genetics. 2020. 61(3), 379-385.
15. Hernandez R, Garcia M, et al. Importance of Maternal Carrier Screening. Prenatal Diagnosis Journal. 2021. 40(6), 455-463.
16. Delatycki MB, Laing NG, et al. Preconception and antenatal carrier screening for genetic conditions: The critical role of general practitioners. Aust J Gen Pract 2019; 48: 106–110.
17. Bajwa H, Basit H. Thalassemia. StatPearls. NCBI. 2023.
18. Kemenkes. Pedoman Nasional Pelayanan Kedokteran Tata Laksana Thalasemia. 2018.
19. .A. W Satyagraha, A. Sadhewa, R. Elvira, et al., Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia, PLoS Negl Trop Dis, 2016 Feb; 10(2): e0004457]
20. S. Nagalia. Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency. Medscape. 2021. https://emedicine.medscape.com/article/200390-overview#showall
21. A. L. Peters and C. J. F. Van Noorden. Glucose-6-phosphate Dehydrogenase Deficiency and Malaria: Cytochemical Detection of Heterozygous G6PD Deficiency in Women, J Histochem Cytochem, 2009 Nov; 57(11): 1003–1011. https://dx.doi.org/10.1369%2Fjhc.2009.953828
22. Wegberg AMJ, MacDonald A, Ahring K, et al. The Complete European Guidelines on Phenylketonuria: Diagnosis and Treatment. Orphanet Journal of Rare Diseases. 2017;12:162. doi: 10.1186/s13023-017-0685-2
23. Rush ET. Phenylketonuria. Medscape. 2018. https://emedicine.medscape.com/article/947781-overview
24. Esmaeilzadeh F, Ahmadi B, et al. Major Thalassemia, Screening or Treatment: An Economic Evaluation Study in Iran. Int J Health Policy Manag. 2022 Jul 1;11(7):1112-1119. doi: 10.34172/ijhpm.2021.04. Epub 2021 Feb 3. PMID: 33619933; PMCID: PMC9808182.
25. Chen HF, Rose AM, et al. Newborn Screening and Treatment of Phenylketonuria: Projected Health Outcomes and Cost-Effectiveness. Children (Basel). 2021 May 12;8(5):381. doi: 10.3390/children8050381. PMID: 34065950; PMCID: PMC8151371.
26. The American College of Obstetricians and Gynecologists (ACOG). Counseling About Genetic Testing and Communication of Genetic Test Results. 2020. https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2017/04/counseling-about-genetic-testing-and-communication-of-genetic-test-results
27. Serapinas, D., Bitinaite , R., et al. False Positive Results in High-Risk Pregnancy for Chromosomal Anomalies: Psychological Considerations. Journal of Advances in Medicine and Medical Research, 35(16), 85–89. 2023.
28. Labonté, V., Alsaid, D., et al. Psychological and social consequences of non-invasive prenatal testing (NIPT): a scoping review. BMC Pregnancy Childbirth 19, 385 (2019).